Literature DB >> 20066732

Tube feeding, the microbiota, and Clostridium difficile infection.

Stephen J D O'Keefe.   

Abstract

Clostridium difficile (C. difficile) is now the leading cause of nosocomial diarrhea in the USA, accounting for 30% of patients with antibiotic-associated diarrhea, 70% of those with antibiotic-associated colitis, and most cases of pseudomembranous colitis. The organism has evolved over the last 8 years to become more virulent and resistant to antimicrobials (NAP1/027 strain) causing a more severe form of the disease that has increased mortality and healthcare costs. While it is generally accepted that the problem results from the overuse of antibiotics, and in particular second and third generation cephalosporins, fluoroquinolones and macrolides, recent studies suggest that acid suppression with proton pump inhibitors (PPIs) may be equally culpable. A further common, but less recognized, etiological factor is the prolonged use of elemental diets. Such diets are totally absorbed within the small intestine and therefore deprive the colonic microbiota of their source of nutrition, namely dietary fiber, fructose oligosaccharides, and resistant starch. The resultant suppression of colonic fermentation leads to suppression of the "good" bacteria, such as butyrate-producers (butyrate being essential for colonic mucosal health), and bifidobacteria and the creation of a "permissive" environment for C. difficile colonization and subsequent infection. Based on this analysis, the best chance of suppressing the emerging C. difficile epidemic is to adopt a 3-pronged attack consisting of (1) avoidance of the use of prophylactic antibiotics, (2) the avoidance of prophylactic PPIs, and (3) the conversion of elemental diet feeding to a diet containing adequate indigestible carbohydrate after the first week of critical illness. In this review, we highlight the rising worldwide incidence of C. difficile associated diarrhea and the role played by non-residue diets in destabilizing the colonic microbiota.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20066732      PMCID: PMC2806551          DOI: 10.3748/wjg.v16.i2.139

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Physiological effects of enteral and parenteral feeding on pancreaticobiliary secretion in humans.

Authors:  Stephen J D O'Keefe; Ronzo B Lee; Frank P Anderson; Chris Gennings; Souheil Abou-Assi; John Clore; Douglas Heuman; William Chey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-01       Impact factor: 4.052

2.  Incidence of Clostridium difficile infection in inflammatory bowel disease.

Authors:  Joseph F Rodemann; Erik R Dubberke; Kimberly A Reske; Da Hea Seo; Christian D Stone
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03       Impact factor: 11.382

3.  Total enteral nutrition or total parenteral nutrition for prophylaxis of infection in patients with severe acute pancreatitis?

Authors:  Stephen J D O'Keefe
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2007-07-17

4.  Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy.

Authors:  Christina Reimer; Bo Søndergaard; Linda Hilsted; Peter Bytzer
Journal:  Gastroenterology       Date:  2009-04-10       Impact factor: 22.682

5.  Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding.

Authors:  D Z Bliss; S Johnson; K Savik; C R Clabots; K Willard; D N Gerding
Journal:  Ann Intern Med       Date:  1998-12-15       Impact factor: 25.391

6.  Effectiveness of liquid soap vs. chlorhexidine gluconate for the removal of Clostridium difficile from bare hands and gloved hands.

Authors:  K Bettin; C Clabots; P Mathie; K Willard; D N Gerding
Journal:  Infect Control Hosp Epidemiol       Date:  1994-11       Impact factor: 3.254

7.  Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study.

Authors:  Stephen Lewis; Stephen Burmeister; Jon Brazier
Journal:  Clin Gastroenterol Hepatol       Date:  2005-05       Impact factor: 11.382

8.  Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea?

Authors:  Robin L P Jump; Michael J Pultz; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

9.  Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.

Authors:  M N Choudhry; H Soran; H M Ziglam
Journal:  QJM       Date:  2008-04-14

10.  Rising economic impact of clostridium difficile-associated disease in adult hospitalized patient population.

Authors:  Xiaoyan Song; John G Bartlett; Kathleen Speck; April Naegeli; Karen Carroll; Trish M Perl
Journal:  Infect Control Hosp Epidemiol       Date:  2008-09       Impact factor: 3.254

View more
  27 in total

1.  Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea.

Authors:  Vijay C Antharam; Eric C Li; Arif Ishmael; Anuj Sharma; Volker Mai; Kenneth H Rand; Gary P Wang
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

2.  Effect of fiber supplementation on the microbiota in critically ill patients.

Authors:  Stephen J D O'Keefe; Junhai Ou; James P Delany; Scott Curry; Erwin Zoetendal; H Rex Gaskins; Scott Gunn
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

Review 3.  Models for the study of Clostridium difficile infection.

Authors:  Emma L Best; Jane Freeman; Mark H Wilcox
Journal:  Gut Microbes       Date:  2012-03-01

4.  Comparative nutritional and chemical phenome of Clostridium difficile isolates determined using phenotype microarrays.

Authors:  Joy Scaria; Jenn-Wei Chen; Nicodemus Useh; Hongxuan He; Sean P McDonough; Chunhong Mao; Bruno Sobral; Yung-Fu Chang
Journal:  Int J Infect Dis       Date:  2014-08-12       Impact factor: 3.623

5.  Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children.

Authors:  Maribeth R Nicholson; Paul D Mitchell; Erin Alexander; Sonia Ballal; Mark Bartlett; Penny Becker; Zev Davidovics; Michael Docktor; Michael Dole; Grace Felix; Jonathan Gisser; Suchitra K Hourigan; M Kyle Jensen; Jess L Kaplan; Judith Kelsen; Melissa Kennedy; Sahil Khanna; Elizabeth Knackstedt; McKenzie Leier; Jeffery Lewis; Ashley Lodarek; Sonia Michail; Maria Oliva-Hemker; Tiffany Patton; Karen Queliza; George H Russell; Namita Singh; Aliza Solomon; David L Suskind; Steven Werlin; Richard Kellermayer; Stacy A Kahn
Journal:  Clin Gastroenterol Hepatol       Date:  2019-04-19       Impact factor: 11.382

6.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

7.  Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection.

Authors:  Susana Fuentes; Els van Nood; Sebastian Tims; Ineke Heikamp-de Jong; Cajo J F ter Braak; Josbert J Keller; Erwin G Zoetendal; Willem M de Vos
Journal:  ISME J       Date:  2014-02-27       Impact factor: 10.302

8.  Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment.

Authors:  Raphael S Rodrigues; Renato A C Oliveira; Yuesheng Li; Snjezana Zaja-Milatovic; Lourrany B Costa; Manuel B Braga Neto; Glynis L Kolling; Aldo A Lima; Richard L Guerrant; Cirle Alcantara Warren
Journal:  J Infect Dis       Date:  2013-01-28       Impact factor: 5.226

9.  Novel risk factors for recurrent Clostridium difficile infection in children.

Authors:  Maribeth R Nicholson; Isaac P Thomsen; James C Slaughter; C Buddy Creech; Kathryn M Edwards
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-01       Impact factor: 2.839

Review 10.  Fiber in the ICU: Should it Be a Regular Part of Feeding?

Authors:  Caitlin H Green; Rebecca A Busch; Jayshil J Patel
Journal:  Curr Gastroenterol Rep       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.